Previously treated cases tested for RR-/MDR-TB (%) in Denmark
Denmark: Previously treated cases tested for RR-/MDR-TB was 81.0% in 2024. ▲ Rising
Latest (2024)
81.0%
Change on year
down 8.0%
World rank
111th
of 180 countries
All-time high
100.0%
in 2019
All-time low
58.0%
in 2007
Years of data
20
2005–2024
Previously treated cases tested for RR-/MDR-TB in Denmark, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Denmark recorded 81.0% for previously treated cases tested for rr-/mdr-tb in 2024.
That represents a change of down 8.0% on the previous year and up 20.9% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Denmark peaked at 100.0% in 2019 and was at its lowest, 58.0%, in 2007.
Denmark ranks 111th of 180 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 20 years of available data.
Previously treated cases tested for RR-/MDR-TB in Denmark, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 62.0% | — |
| 2006 | 63.0% | +1.6% |
| 2007 | 58.0% | -7.9% |
| 2008 | 76.0% | +31.0% |
| 2009 | 76.0% | +0.0% |
| 2010 | 80.0% | +5.3% |
| 2011 | 64.0% | -20.0% |
| 2012 | 81.0% | +26.6% |
| 2013 | 77.0% | -4.9% |
| 2014 | 67.0% | -13.0% |
| 2015 | 59.0% | -11.9% |
| 2016 | 58.0% | -1.7% |
| 2017 | 73.0% | +25.9% |
| 2018 | 87.0% | +19.2% |
| 2019 | 100.0% | +14.9% |
| 2020 | 100.0% | +0.0% |
| 2021 | 86.0% | -14.0% |
| 2022 | 93.0% | +8.1% |
| 2023 | 88.0% | -5.4% |
| 2024 | 81.0% | -8.0% |
Denmark compared with similar countries
- Denmark's 81.0% is below the median for high income countries, which is 83.0%, 98% of the median. (57 countries reporting)
- Denmark's 81.0% is below the median for Europe & Central Asia, which is 86.0%, 94% of the median. (49 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 67.0% | 58.0% | 76.0% | 5 |
| 2010s | 74.6% | 58.0% | 100.0% | 10 |
| 2020s | 89.6% | 81.0% | 100.0% | 5 |
Countries ranked near Denmark
More health data for Denmark
- Un projection of annual infant deaths, annual growth rate -3.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1019 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,179 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.4524 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0247 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.4338 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Denmark?
- Previously treated cases tested for rr-/mdr-tb in Denmark was 81.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Denmark?
- The highest recorded value was 100.0% in 2019.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Denmark?
- The lowest recorded value was 58.0% in 2007.
- How does Denmark rank for previously treated cases tested for rr-/mdr-tb?
- Denmark ranks 111th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Denmark?
- Over the last ten years it is up 20.9%. The long-run trend across the full record is rising.
- Where does this Denmark data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).